Articles

A Systematic Review and Meta-Analysis of the CancerRelated and Functional Outcomes of High-Intensity Focused Ultrasound, Open Radical Prostatectomy, Robot Assisted Radical Prostatectomy, and External Beam Radiation Therapy in Primary Treatment of Localized Low- or Intermediate-Risk Prostate Cancer

Volume 50 · Issue 1 Publish Date: January 31, 2024
Full Text PDF
DOI
Bassem Toeama
University of Toronto, Faculty of Pharmacy, Ontario, Canada
Emmanuel Papadimitropoulos
University of Toronto, Faculty of Pharmacy, Ontario, Canada
Nathan Perlis
University of Toronto, Faculty of Medicine, Ontario, Canada
Paul Grootendorst
University of Toronto, Faculty of Pharmacy, Ontario, Canada
Bassem Hamandi
University of Toronto, Faculty of Pharmacy, Ontario, Canada
Full Text Full Text PDF

Abstract

Objective: Prostate cancer is the second- leading cause of cancer death among men. We aimed to evaluate high-intensity focused ultrasound (HIFU), open radical prostatectomy (ORP), robot-assisted radical prostatectomy (RARP), and external beam radiation therapy (RT) in the treatment of localized low- and intermediate-risk prostate cancer.

Methods: We searched bibliographic databases for case–control, cohort, and randomized controlled studies. We used MeSH subject headings and free text terms for prostate cancer, HIFU, ORP, RARP, RT, failure-free survival (FFS), biochemical disease-free survival (BDFS), urinary incontinence (UI), and erectile dysfunction (ED).

Results: Fourteen studies were included in the review, for a total of 34 927 participants. Among the 8 studies of HIFU as the primary treatment of localized low- and intermediate-risk prostate cancer, 4 studies reported 5-year FFS rates ranging from 67.8% to 97.8%, 3 studies reported 5-year BDFS ranging from 58% to 85.4%, 5 studies reported 1-year UI rates ranging from 0% to 6%, and 4 studies reported 1-year ED rates ranging from 11.4% to 38.7%. Furthermore, our search revealed a 5-year FFS benefit favoring ORP compared to RT, a 1-year UI rate favoring ORP compared to RARP, and a 1-year ED rate favoring ORP compared to RARP.

Conclusion: Our systematic review and meta-analysis revealed lack of studies with active comparators comparing HIFU to standard of care (ORP, RARP, or RT) in primary treatment of localized low- and intermediate-risk prostate cancer. Open radical prostatectomy has favorable efficacy outcomes compared to RT, while RARP has beneficial functional outcomes compared to ORP, respectively.

Cite this article as: Toeama B, Papadimitropoulos E, Perlis N, Grootendorst P, Hamandi B. A systematic review and meta-analysis of the cancer-related and functional outcomes of high intensity focused ultrasound, open radical prostatectomy, robot assisted radical prostatectomy, and external beam radiation therapy in primary treatment of localized low or intermediate risk prostate cancer. Urol Res Pract. 2024;50(1):1-12.

Similar Articles

Article Info
Published In
Journal Urology Research & Practice
Volume / Issue Volume 50 · Issue 1
Pages 1-12
History
Published Online January 31, 2024
Copyright
Affiliations
Bassem Toeama
University of Toronto, Faculty of Pharmacy, Ontario, Canada
Emmanuel Papadimitropoulos
University of Toronto, Faculty of Pharmacy, Ontario, Canada
Nathan Perlis
University of Toronto, Faculty of Medicine, Ontario, Canada
Paul Grootendorst
University of Toronto, Faculty of Pharmacy, Ontario, Canada
Bassem Hamandi
University of Toronto, Faculty of Pharmacy, Ontario, Canada
Cite this Article
Outlines